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ABSTRACT 
Background: Drugs have become one of an essential component of healthcare systems worldwide. However, there is a concern for 
their safety. Adverse drug reaction (ADR) is common during usual clinical practice and it is associated with increased morbidity, 
hospitalization and mortality. 
Objective: To assess knowledge, attitude, and practice of healthcare professionals (HCPs) towards ADRs reporting at inpatient 
wards of Tikur Anbessa Specialized Hospital (TASH), Ethiopia. 
Methods: Hospital based descriptive cross-sectional study was conducted among 280 HCPs at the inpatient wards of TASH. The 
data required for the present study was collected using self-administered structured questionnaire and samples were selected through 
both stratified and systematic random sampling methods, where the type of profession was used as a stratum. The collected data was 
analyzed using SPSS version 21.00 for the window. 
Results: Of 280 HCPs to whom the questionnaire initially administered, 213 respondents filled and returned the questionnaire, 
giving a response rate of 76.1%, and were included in the analysis. The study revealed that 78.9% and 47.9% of HCPs have poor 
knowledge and negative attitude towards ADR reporting respectively.  Among respondents, 38% of HCPs encountered patient with 
ADR, 90.2% of them reported the ADR they encountered, of them only 10.8% were reported to Ethiopian food, medicine, and 
healthcare administration and control authority, a regulatory body for receiving and monitoring ADR throughout the country. 
Conclusion: HCPs in TASH had poor knowledge, attitude and practice towards ADRs reporting. The hospital should devise 
strategies to enhance detection and reporting of ADRs. 
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INTRODUCTION 
According to World Health Organization (WHO) 
definition, an ADR is any noxious and unintended effect 
of a drug, which occurs at doses used in humans for 
prophylaxis, diagnosis or cure of a disease 
1
.  Drugs play 
important role in day to day life of the human being to 
prevent and treat diseases as well as maintain overall 
wellbeing. Despite multiple benefit of drugs, they are 
not totally free from untoward effects. 
2,3
 
 Post-marketing surveillance of drugs was used as an 
important tool in controlling drug safety for century; 
contributed a lot in the withdrawal of drugs from the 
market due to safety problem. Reporting ADRs is 
important for all types of drugs, whether newly released 
into market or renowned since ADR can be caused by 
any type of drug at any time.  In spite of the necessity of 
continuous reporting and monitoring of ADRs to 
minimize its consequence, the practice is still poor 
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particularity in developing countries because it requires 
adequate knowledge, skills, attitude and commitment by 
healthcare professionals and strict regulation and 
monitoring by drug regulatory bodies 
2,4
. 
Spontaneous reporting structure, a system whereby 
reports of ADRs are voluntarily submitted by HCPs and 
pharmaceutical manufacturers to national regulatory 
authority, is the most common way through which 
regulatory bodies collect information on ADRs 
5,6
.  
Spontaneous reporting of ADRs remains the cornerstone 
of pharmacovigilance. However, the success of this 
activity is dependent on the reporting of all suspected 
ADRs by HCPs, which in turn affected by knowledge, 
attitude and commitments of HCPs. In western countries 
the incidence of ADRs is 2.4-6.5% of which only 6-10% 
of all ADRs being reported 
7,8
.  
A Number of factors might be attributed for 
underreporting of ADRs which include fearing to report,  
lack of   time, different care priorities, uncertainty about 
the drug causing the ADR, difficulty in accessing 
reporting forms, lack of awareness of the requirements 
for reporting, unawareness about where to report and 
how to report, lack of feedback from regulatory 
authority and lack of understanding the purpose of 
spontaneous reporting systems 
9–12
. 
In Ethiopia voluntary ADR reporting has been effective 
since 2002 through the rigorous activities performed by 
the ADR monitoring division of the EFMHACA aimed 
to reduce ADR. A simple ADR reporting form was 
developed and it is made available in all health facilities 
across the country for identifying and reporting ADR. 
However, the number of reports received by the center 
still is small 
6,13
.  
METHODS 
Study Setting 
The study was conducted at inpatient wards of Tikur 
Anbessa Specialized Hospital (TASH), the largest 
referral hospital with over 700 beds, located in Addis 
Ababa, Ethiopia. The hospital provides services for 
people coming from different corners of the country. 
The hospital inpatient wards provide services with 14 
physicians, 633 nurses and midwives, 76 pharmacists 
and 33 anesthetists who were hired to provide healthcare 
services. There was no well-established 
pharmacovigilance center in TASH. 
Study Design and Period 
A cross sectional study with two stage sampling, both 
stratified and systematic random sampling techniques, 
was conducted among HCPs. The data was collected 
from March 3-25, 2016 at inpatient wards of TASH. 
Respondents included in this study were those HCPs 
working at inpatient wards of TASH who were available 
during data collection period and willing to participate.  
HCPs practicing in TASH but not hired by the hospital 
(i.e. students) were excluded from the study. 
Sample size determination and sampling procedure 
Sample size required for the present study was 
calculated using the following single population 
proportion formula. 
n = 
           
  
 
When we take two tailed Zα/2 value of 95% confidence 
interval (1.96), 50% prevalence of ADR reporting 
knowledge and 5% of marginal error (d), the sample size 
was 384. There were 756 HCPs (N= 756) who fulfilled 
the inclusion criteria of the study. Since this number is 
less than 10,000, the sample size has been corrected 
using the following sample correction formula. The 
corrected sample size hence was 255; including a 10% 
non-response rate yielded a final sample size of 280. 
Corrected sample size = 
   
   
 
After having the determined sample size, samples for 
the study were proportionally stratified based on 
profession. Systematic random sampling technique was 
used with sampling fraction (k) which was varied for 
each profession. The sample size was distributed over 
professions based on their proportion from the total 
HCPs. Accordingly; questionnaires were administered 
to 5 physicians, 12 anesthetists, 28 pharmacists and 235 
nurses.  
Data collection Instrument and interpretation of 
result 
Data was collected using structured self-administered 
questionnaire with information on socio-demographic 
characteristics, knowledge, attitude and practice on 
ADRs reporting adapted from reviewing different 
literatures and previous studies 
11,14–18
.  
The questionnaire includes 7 questions to assess HCPs’ 
knowledge on ADRs reporting. A knowledge score was 
prepared as a guiding tool to assess knowledge, whereby 
one point for correct answer and zero for wrong answer. 
HCPs were categorized based on their overall 
knowledge scores using original Bloom’s cutoff points. 
The score ranges with their respective knowledge levels 
were: 80-100%, 60-79% and <60% of maximum score 
as good, moderate and poor knowledge respectively. 
There were 9 questions in the attitude part.  Respondents 
were asked to indicate their level of agreement or 
disagreements on a five point Likert scale containing 
‘Strongly agree’, ‘agree’, ‘neutral’, ‘disagree’ and 
‘Strongly disagree’ on the scale, valued 5 to 1 
respectively. The interpretation for negatively worded 
questions was reversed. The sum of all items will give 
maximum score of 45. Seventy five percent of the 
maximum score i.e. a score of 33.75 was taken as a 
cutoff point to categorize respondents into two 
categories, greater than and equal to 33.75 were 
categorized as having positive attitude and those who 
scored less than 33.75 were categorized as having 
negative attitude towards ADR reporting. Five questions 
were used to assess respondents’ practice towards ADRs 
reporting. The data was entered and analyzed using 
SPSS version 21.0. It was summarized as frequency and 
percentage. 
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Data quality assurance and quality control 
The questionnaire was pretested on 14 HCPs working at 
Mizan Tepi University Teaching hospital to check its 
suitability for the actual data collection. Before starting 
data collection, brief explanation on how to fill the 
questionnaire was given for each health professionals. 
The questionnaire was checked for completeness by 
principal investigator. 
Ethical consideration: Before the actual data collection 
process, an official cooperation letter was obtained from 
Mizan-Tepi University, college of health sciences and 
submitted to clinical director of TASH, then data 
collection was commenced after permission from the 
director. Brief explanation on objective of the study was 
given for HCPs and written consent was secured. 
RESULTS 
Background characteristics of participants 
 Self-administer questionnaire was distributed to 280 
HCPs working at inpatient wards of TASH. Among 
HCPs initially approached, only 213 HCPs adequately 
filled and returned the questionnaires, giving a response 
rate of 76.1 %.  Hence, 213 HCPs were considered for 
analysis. Females comprised 54% of the respondents.  
Most of the respondents were in the age range of 26-35 
years, which accounted for 51.1%. Nurses comprised 
the major type of HCPs included in the study accounted 
for 75.6% of the respondents. Majority, 192(90.1%) of 
the respondents were bachelor degree holders. One 
hundred twenty two (57.3%) HCPs were having a 
clinical experience of 1-5 years (Table 1).
 
Table 1: Background characteristics of HCPs at inpatient wards of TASH (N=213), March, 2016  
Variables  Category  Frequency (%) 
Sex Female 115(54.0) 
Male  98(46.0) 
 
Age 
 25 85 (39.9) 
26-35 109 (51.1) 
36-45 11 (5.2) 
 45 8 (3.8) 
 
     
Profession 
Nurse 161(75.6) 
Pharmacist 27(12.7) 
Anesthetist 10(4.7) 
Midwife 10(4.7) 
Physician  5(2.3) 
  
Level of education 
Diploma  8(3.8) 
Bachelor degree 192(90.1) 
MSc or equivalent 13(6.1) 
 
Years of clinical experience 
< 1 year 33 (15.5) 
1-5 years 122 (57.3) 
 5 years 58(27.2) 
 
Table 2: Knowledge of HCPs at inpatient wards of TASH on ADR Reporting, March, 2016 
Questions Yes, Number (%) 
1. Differentiate ADR from drug side effect 114(53.5) 
2. Know the term pharmacovigilance 66(31.0) 
3. Know the existence of national ADR monitoring system 78(36.6) 
4. Know the ADR reporting form 59(27.7) 
5. ADRs are not well documented at the time the drug is marketed 140(65.7) 
6. Where to send ADR report  
6.1.  MOH   29(13.6) 
6.2.  FMHACA* 106(49.8) 
6.3.  PFSA 18(8.4) 
6.4.  EPA 45(21.2) 
6.5.  Do not know 15(7) 
7. Types of medication candidate for ADR reporting  
7.1.  Conventional medicines 117(54.9) 
7.2.  Vaccines and blood products 106(49.8) 
7.3.  Traditional medicines 35(16.4) 
7.4.  Medicated cosmetics  64(30.0) 
7.5.  Medical devices 86(40.4) 
7.6.  All (7.1. to 7.5)* 7(3.3) 
*correct knowledge, MOH: Ministry of health, FMHACA: food, medicine, healthcare administrative and control authority, PFSA: 
pharmaceutical fund and supply agency, EPA: Ethiopian pharmaceutical association 
Kefale et al                                                                                                           Journal of Drug Delivery & Therapeutics. 2017; 7(4):97-102                         
ISSN: 2250-1177                                                                              [100]                                                                            CODEN (USA): JDDTAO 
Knowledge of HCPs on ADRs reporting 
Upon analysis of questions that were used to assess 
knowledge, the result revealed that 21(9.8%), 24(11.3%) 
and 168(78.9%) HCPs have good, moderate and poor 
knowledge on ADR reporting, respectively. Among the 
respondents, 106 (49.8%) knew the responsible body to 
whom ADR should be reported (Table 2).  As per 
Ethiopian context, FMHACA is a regulatory body 
responsible for receiving and monitoring ADR reports. 
Attitude of the HCPs towards ADR reporting 
The present study found that 186 (87.3%) HCPs agreed 
on regular reporting of ADR, and 179(84%) HCPs 
agreed on ADR reporting as part of duty of health 
professionals. In addition, 192(90.1%) agreed on its 
importance for the patient and 117(54.9%) agreed on 
reporting ADR should be mandatory (Table 3). Overall, 
52.1% of HCPs had positive attitude towards ADR 
reporting.
 
Table 3: Attitude of HCPs at inpatient wards of TASH on ADR Reporting, March, 2016 
Statements SA Agree Neutral disagree SDA 
1. ADR should be reported regularly 118(55.4) 68(31.9) 5(2.3) 10(4.7) 12(5.6) 
2. ADR reporting is part of duty of health professionals 107(50.2) 72(33.8) 12(5.6) 11(5.2) 10(4.7) 
3. ADR reporting is important for the patient 140(65.7) 52(24.4) 11(5.2) 10(4.7) 0(0) 
4.  ADR reporting is important for the public 103(48.4) 79(37.1) 18(8.4) 4(1.9%) 9(4.2%) 
5. ADR reporting is important for the health care system 131(61.5) 66(31) 11(5.2) 2(0.9%) 2(0.9) 
6. There is a need to be sure that ADR is related to the 
drug before  reporting 
98(46.0) 66(31.0) 29(13.6) 18(8.4) 2(0.9) 
7. Only ADRs of prescription drugs need to be reported 36(16.9) 58(27.2) 31(14.6) 67(31.4) 18(8.4) 
8. Only  ADRs that cause persistent disability or 
incapability should be reported  
32(15) 43(20.2) 18(8.4) 62(29.1%) 58(27.2) 
9. Reporting of ADR should be voluntary 36(16.9) 31(14.5) 29(13.6) 51(23.9) 66(31) 
SA: strongly agree, SDA: strongly disagree 
 
Practice of the HCPs towards ADR reporting 
This study revealed that 82(38.5%) HCPs encountered 
at least one patient with ADR during their clinical 
practice in the last one year. Seventy four (90.2%) HCPs 
reported the ADR they encountered, of which only 
8(10.8%) reported to the appropriate body, FMHACA. 
Among the respondents 82(38.5%) HCPs claimed they 
usually give advice to their patients on possible ADRs 
of drugs (Table 4). 
 
Table 4: ADR reporting practice of HCPs at inpatient wards of TASH, March, 2016  
Variables Yes, Frequency (%) 
1. Encountered patient with ADR during the last 12 months 82 (38.5%) 
2. Number of patients  encountered with ADR (N=82)  
             One  30(36.6) 
             Two  30(36.6) 
             Three  8(9.8) 
              Four  9(11.0) 
             ≥ Five  5(6.0) 
3. Usually give advice to patients on possible adverse effects of the drugs 82 (38.5%) 
Reported the ADRs encountered 74 (90.2%) 
To whom ADR reported (N=74)  
              Head of the pharmacy 28(37.8) 
              Manufacturers  6(8.1) 
              MOH 16(21.6) 
              Physician  10(13.5) 
              FMHACA 8(10.8) 
              Head nurse 3(4.1) 
              Other*  3(4.1) 
4. Advice patients about possible adverse effects of drugs  
              Usually  82(38.5) 
              Sometimes  61(28.6) 
              Rarely  53(24.9) 
              Never  17(8) 
*Ethiopian Pharmaceutical A association, wholesale 
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DISCUSSION 
Adverse drug reactions result in an excessive healthcare 
costs through increased morbidity, mortality and 
hospital admissions. Therefore, monitoring of ADRs is 
an integral component of patient care.  The study was 
conducted among 213 HCPs working at TASH inpatient 
wards to assess their knowledge and attitude towards 
ADR reporting as well as to evaluate the practice of 
encountered ADR reporting. The study included 
physicians, pharmacists, nurses, midwives and 
anaesthetists.  
In the current study, out of 213 HCPs, only 53.5% said 
that ADR is different from side effect, but only 31% 
reported that they knew the term pharmacovigilance. As 
per WHO recommendation, the term side effect should 
be reserved for minor effects of drug which are related 
with its pharmacological properties 
19
. There is a need to 
work to upgrade knowledge of professionals on different 
form of unintended effects of drugs. This helps for 
professionals to differential things to be reported from 
minor side effects.     
Among the respondents, 63.4% knew the presence of 
national ADR reporting system, which is greater than  
45.2 % 
16
, 37.4% 
20
, 23.2% 
18
 reported by previous 
studies conducted in other health facilities in Ethiopia.  
This might be the difference in access to information 
about the presence of ADR reporting centre. Health 
professionals in TASH could have better information 
access than those working in peripheral part of the 
country, with better media outlet in the capital, Addis 
Ababa. Despite slightly higher knowledge about 
physical presence of ADR reporting centre as compared 
with reported from other part of the country, only 27.7% 
of HCPs knew the ADR reporting form. This result is 
almost consistent with 25.6% reported by Angamo et al 
18
, but higher as compared  to 20.6% reported from 
Jimma zone hospitals in Ethiopia 
20
. However, this 
finding was lower than the result found in Uganda, 
37.7% 
15
 and Ethiopia, 48.7% 
16
. The regulatory body 
should enhance the distribution of prepaid report form to 
different wards of TASH. 
This study found out that 87.3% of HCPs agreed the fact 
that ADR should be reported spontaneously at regular 
basis, which is in line with the findings from similar 
study in Addis Ababa, 88.9% 
21
. The present study 
showed that 84% of healthcare professionals believed 
ADR reporting as part of duty of health professionals, 
which is relatively comparable with the 78.3% obtained 
from Nekemte, Ethiopia 
16
, but lower than the results 
reported from Addis Ababa, 96.6% 
22
 and 92.7% 
21
. The 
result of this study revealed that 90.1%, 85.5% and 
92.5% of HCPs believed that ADR reporting is 
important for the patient, public and healthcare system 
respectively.  One hundred six four HCPs (77%) 
claimed that there is the need to be sure that ADR is 
related with the drug before reporting. The study 
conducted in Jimma and Addis Ababa revealed that 
85.4% and 76.9% of study respondents, respectively, 
believed the need to be sure that ADR is attributed to the 
suspected drug 
18,21
. 
This study revealed that 38% in contrast with 81% in 
Northern Nigeria 
14
 and 11.3% in Nekemte hospital 
16
 of 
the respondents encountered at least one patient with 
ADR during their clinical practice in the last one year. 
Among those HCPs who encountered ADRs, 90.2% 
claimed that they have reported the ADR, despite only 
10.8% reported to appropriate body, FMHACA. This 
showed that most of the healthcare professionals who 
recognized ADR did not report to the concerned body. 
This might be due unavailability of reporting form in 
wards and lack of awareness of the existence of 
reporting centre.  
Limitations of the present study includes possibility of 
recall bias and the result of the study does not claim to 
represent all healthcare professionals in TASH, as the 
respondents were recruited only from inpatient wards. 
CONCLUSIONS AND 
RECOMMENDATIONS 
The present study identified that healthcare 
professionals working in the TASH, Addis Ababa, 
Ethiopia had poor knowledge, attitude and practice 
towards ADRs reporting. This study strongly suggests 
TASH inpatient ward coordinators to facilitate training 
programs regarding the importance of ADR reporting to 
improve knowledge, attitude and practice of healthcare 
professionals.  
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